Leukemia Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Acute Myeloid Leukemia (AML)

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ? 18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

Acute Myeloid Leukemia (AML)

Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (? 60 […]

Chronic Lymphocytic Leukemia (CLL)

A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

Chronic Lymphocytic Leukemia (CLL)

A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated […]

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Leukemia

A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients ?18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy

Leukemia

A Multicenter, Open-Label Phase 1b Study to Assess Safety and Efficacy of Venetoclax in Combination with Gilteritinib in Subjects with Relapsed/Refractory Acute Myeloid Leukemia.

Lymphoma

A PHASE 1/2A OPEN-LABEL, MULTI-DOSE, MULTI-CENTER ESCALATION AND EXPLORATORY STUDY OF CERDULATINIB(PRT062070) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) OR B-CELL or T-CELL NON-HODGKIN LYMPHOMA (NHL)

Myeloproliferative Neoplasms

SL-401 in Patients With Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Primary Eosinophilic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story
Related Stories

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.